Tag Archives: business

Scientists look for new antimicrobials and urge government incentives

Photo: CDC/ Melissa Dankel

Researchers are looking to old drugs, plants and viruses in a race to find new ways to kill disease-causing microbes before they become resistant to all existing pharmaceuticals, but their work will flounder if the federal government can’t figure out how to incentive companies to turn their work into commercially viable drugs. Continue reading

Primary care physicians find value-based payments fail to cover their costs

It’s hard to imagine any physician starting an online fundraising effort to keep her practice open. But for Michelle Mitchell, M.D., a solo physician who runs Hawaii Family Health, the business model for primary care in her state is unsustainable otherwise.

She wants to raise $250,000 via a GoFundMe page that explains many of the financial problems she and her 15-member staff face running a practice that serves 2,500 patients in Hilo, the capital of the Big Island.   Continue reading

Consider the business angle when covering antibiotic resistance

Photo: NIAID via Flickr

In early October, the U.S. Food and Drug Administration approved Paratek Pharmaceuticals’ new antibiotic Nuzyra, which kills bacteria associated with skin and lung infections.

The approval was notable because there are so few new antibiotics coming onto the market, , says journalist Maryn McKenna in Wired magazine, largely because most drug companies don’t think antibiotics — which have wiped out the threat of many infectious diseases — to be worth the investment.

The problem is a unique business and policy dilemma for society. Continue reading

How to discover and dissect surprise medical bills

Kaiser Health News and NPR have been collaborating on a series called Bill of the Month. This piece by KHN’s Chad Terhune was one of the most memorable. Like many of these articles, it got results – the story got a ton of attention, outrage was generated and voila, the bill was lowered. It was cited by a bipartisan group of senators who introduced legislation curbing the practice of “surprise billing.”

Continue reading

CVS-Aetna merger approval raises questions about competition and drug costs

Photo: afagen via Flickr

The merger of CVS Health, one of the nation’s largest pharmacy retailers, with third-largest health insurer Aetna has the potential to transform the health care system and raises concerns about the effect the merger could have on drug prices and competition. This would be the first time that a large pharmacy retailer gains control of one of the nation’s largest health insurers. CVS Health not only has 9,800 retail outlets in nearly every state (except Wyoming), but also 94 million members in pharmacy benefit manager CVS/Caremark. Continue reading